| 177Lu-PSMA-I&T Prior to Radical Prostatectomy for Locally Advanced Disease (NCT04297410) | Rabin Medical Center | 2019-11-20 |
| Assessment of Multi-Modality Quantitative Imaging for Evaluation of Response of Metastatic Prostate Cancer to Therapy (NCT03619655) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2019-11-15 |
| (SGB) in Men Treated for Prostate Cancer Improve Hot Flashes (NCT03796195) | Northwestern University | 2019-11-13 |
| Use of Indocyanine Green During Pelvic Lymph Node Dissection in Prostate Cancer. (NCT04882618) | TC Erciyes University | 2019-11-08 |
| Real Time MRI Fused to Cone Beam CT Guided Biopsies of the Prostate. (NCT04180592) | Queen's University | 2019-11-06 |
| Fear of Cancer Recurrence in Genitourinary Cancer (NCT04535921) | Ludwig-Maximilians - University of Munich | 2019-11-05 |
| MSG Use With 18F-DCFPyL PET/CT Imaging (NCT03693742) | British Columbia Cancer Agency | 2019-11-04 |
| Dynamic Whole Body Positron Emission Tomography/Computed Tomography Imaging (NCT04017104) | British Columbia Cancer Agency | 2019-11-01 |
| PROCLAIM: Germline Genetic Testing for Prostate Cancer Patients (NCT05447637) | Invitae Corporation | 2019-11-01 |
| Targeting Resistant Prostate Cancer With ATR and PARP Inhibition (TRAP Trial) (NCT03787680) | University of Michigan Rogel Cancer Center | 2019-10-31 |
| Neoadjuvant Atezolizumab-Based Combination Therapy in Men With Localized Prostate Cancer Prior to Radical Prostatectomy (NCT03821246) | David Oh | 2019-10-30 |
| Fecal Microbiota Transplant and Pembrolizumab for Men With Metastatic Castration Resistant Prostate Cancer. (NCT04116775) | Julie Graff, MD | 2019-10-30 |
| Clinico-biological Database in Patients Treated With Metabolic Radiotherapy in the Nuclear Medicine Department (NCT04104529) | Institut du Cancer de Montpellier - Val d'Aurelle | 2019-10-28 |
| Soccer Intervention in Prostate Cancer Survivors (NCT04144127) | Emory University | 2019-10-25 |
| Stereotactic Magnetic Resonance Guided Radiation Therapy (NCT04115254) | Dana-Farber Cancer Institute | 2019-10-22 |
| ReIMAGINE Prostate Cancer Screening (NCT04063566) | University College, London | 2019-10-21 |
| pTVG-HP DNA Vaccine With or Without pTVG-AR DNA Vaccine and Pembrolizumab in Patients With Castration-Resistant, Metastatic Prostate Cancer (NCT04090528) | University of Wisconsin, Madison | 2019-10-21 |
| Study of NGM120 in Subjects With Advanced Solid Tumors, Pancreatic Cancer, and Prostate Cancer Using Combination Therapy (NCT04068896) | NGM Biopharmaceuticals, Inc | 2019-10-16 |
| Role of Lymphnode Dissection in Men With Prostate Cancer Treated With Radical Prostatectomy (NCT04269512) | Martini-Klinik am UKE GmbH | 2019-10-15 |
| Early Prostate Cancer Recurrence With PSMA PET Positive Unilateral Pelvic Lesion(s) (NCT04271579) | Martini-Klinik am UKE GmbH | 2019-10-15 |
| Trial of Community Health Worker-led Decision Coaching (NCT03726320) | NYU Langone Health | 2019-10-15 |
| CASCARA: Castration Sensitive Carboplatin, Cabazitaxel and Abiraterone (NCT03934840) | Masonic Cancer Center, University of Minnesota | 2019-10-10 |
| Naptumomab Estafenatox in Combination With Durvalumab in Subjects With Selected Advanced or Metastatic Solid Tumor, Including a Cohort Expansion in Esophageal Cancer. (NCT03983954) | NeoTX Therapeutics Ltd. | 2019-10-10 |
| A Study of Ladiratuzumab Vedotin in Advanced Solid Tumors (NCT04032704) | Seagen Inc. | 2019-10-09 |
| Microwave Needle Thermoablation for Treatment of Localized Prostate Cancer (NCT04113811) | Chinese University of Hong Kong | 2019-10-08 |
| Erectile Dysfunction in Good Prognosis Prostate Cancer : Comparison Between Brachytherapy and Stereotactic Body Radiotherapy (NCT03830788) | Center Eugene Marquis | 2019-10-04 |
| How Does Prostate Cancer Metastasize? Studying the Role of Secreted Packages (Exosomes) From Fat Tissue in Lean and Obese Patients (NCT04167722) | Imperial College London | 2019-10-01 |
| The Prostate Liquid Study (PLiS) (NCT04102904) | University College, London | 2019-10-01 |
| Study of 18F-DCFPyL PET/CT Imaging in Patients With Prostate Cancer (NCT03800784) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2019-10-01 |
| Active Surveillance for Low Risk Prostate Cancer (NCT04146077) | I.M. Sechenov First Moscow State Medical University | 2019-10-01 |
| A Trial Evaluating Toxicity of SBRT and LDRB in Localized Prostate Cancer. (NCT06052683) | CHU de Quebec-Universite Laval | 2019-09-30 |
| Prediction of the PRONOUNCE Prostate Cancer Trial in Healthcare Claims Data (NCT04897958) | Brigham and Women's Hospital | 2019-09-21 |
| HoLEP Prior to Radiation Therapy for Patients With LUTS/Retention and Concurrent Prostate Cancer (NCT03802851) | University of Kansas Medical Center | 2019-09-19 |
| Study to Evaluate the Safety of Nanoxel M Inj. (NCT04066335) | Samyang Biopharmaceuticals Corporation | 2019-09-18 |
| Optimizing Prostate Cancer Treatment in Men With Advanced Local Disease (NCT03836196) | British Columbia Cancer Agency | 2019-09-13 |
| Using PSMA PET-CT as a Diagnostic Tool for Detection of Prostatic Cancer at an Early Stage (NCT04116086) | Sheba Medical Center | 2019-09-11 |
| Development of a Therapeutic Education Program for Patients With Metastatic Prostate Cancer Treated With New Generation Hormone Therapy (NCT04048252) | Centre Hospitalier Universitaire de Nīmes | 2019-09-10 |
| Single-center Trial for the Validation of High-resolution Transrectal Ultrasound (Exact Imaging Scanner ExactVu) for the Detection of Prostate Cancer (NCT03679819) | Institut Paoli-Calmettes | 2019-09-05 |
| MR Radiomic Features in Prostate Cancer (NCT04219059) | IRCCS San Raffaele | 2019-09-03 |
| Postop Hypofractionated Radiation Therapy and LHRH in Patients With Prostate Cancer (NCT04249154) | McGill University Health Centre/Research Institute of the McGill University Health Centre | 2019-09-03 |
| ReIMAGINE Prostate Cancer Risk (NCT04060589) | University College, London | 2019-09-03 |
| Biomarker Analysis of Castration-resistant Prostate Cancer Undergoing Treatment With Docetaxel Followed by Enzalutamide (NCT03700099) | Instituto do Cancer do Estado de São Paulo | 2019-09-03 |
| Prostate Biopsy, Transrectal vs. Transperineal: Efficacy and Complications (NCT04081636) | Albany Medical College | 2019-09-02 |
| Influence of Prostate Cancer Radiation on Aging (NCT04321187) | Medical University of Graz | 2019-09-01 |
| Evaluation of the PI-RADS v2.1 Score Using Multiple Readers (NCT04299997) | Hospices Civils de Lyon | 2019-09-01 |
| Effects of Kieser Resistance Training Plus Kieser Pelvic Floor Training vs. Kieser Resistance Training Plus Traditional Pelvic Floor Exercise on Urinary Incontinence in Prostate Cancer Patients After Radical Prostatectomy (NCT06206993) | University Hospital Heidelberg | 2019-09-01 |
| MISOBOLD - Prostate Cancer Hypoxia Using BOLD MRI and 18F-MISO PET Imaging (NCT03293602) | University Hospital, Bordeaux | 2019-09-01 |
| Adjuvant Chemotherapy for High Malignant Prostate Cancer (NCT06864533) | Peking University First Hospital | 2019-09-01 |
| An Open-label, Phase II Study of AZD4635 in Patients With Prostate Cancer (NCT04089553) | AstraZeneca | 2019-08-29 |
| Neoadjuvant Dupilumab in Men With Localized High-Risk Prostate Cancer (NCT03886493) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2019-08-28 |
| Extended Pelvic Lymph Node Dissection vs. no Pelvic Lymph Node Dissection at Radical Prostatectomy for intermediate-and High-risk Prostate Cancer (NCT03921996) | Swiss Cancer Institute | 2019-08-27 |
| FIRMAGON® Intensive Drug Monitoring (NCT05181800) | Ferring Pharmaceuticals | 2019-08-20 |
| Exercise and Quality of Life During Androgen Deprivation Therapy (NCT04050397) | Tampere University Hospital | 2019-08-15 |
| A Study to Evaluate ONM-100, an Intraoperative Fluorescence Imaging Agent for the Detection of Cancer (NCT03735680) | OncoNano Medicine, Inc. | 2019-08-09 |
| RAdium-223 and SABR Versus SABR for Oligometastatic Prostate Cancers (NCT04037358) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2019-08-09 |
| Focal Laser Ablation for the Treatment of Focal Low-Intermediate Risk Prostate Cancer (NCT04045756) | University of Rome Tor Vergata | 2019-08-02 |
| Improvement of Communicational Skills Between Health Workers and Oncological Patients During Medical Consultative Conversations (NCT04506710) | I.M. Sechenov First Moscow State Medical University | 2019-08-01 |
| Rectal Gas Removal Through Small Catheter Placement Prior to MRI of the Prostate (NCT03987737) | Universitaire Ziekenhuizen KU Leuven | 2019-08-01 |
| Changes in Body Composition With Patients Under Androgen Deprivation Therapy (NCT04037488) | Seoul National University Hospital | 2019-08-01 |
| Prostate Margin Reduction to Reduce Acute Rectal Toxicity (PROTRACT) (NCT04004858) | Southlake Health | 2019-08-01 |
| Prostate-Specific Membrane Antigen (PSMA) PET Scans in People Prostate Cancer (NCT04030338) | Memorial Sloan Kettering Cancer Center | 2019-07-19 |
| Mobile Health App to Mitigate the Metabolic Effects of Androgen Deprivation Therapy (NCT03761160) | Dana-Farber Cancer Institute | 2019-07-16 |
| Telomere Associated Variables (TAVs) in Prostate Cancer (NCT04124900) | Life Length SL | 2019-07-15 |
| Walking Football as a Supportive Medicine for Patients With Prostate Cancer (NCT04062162) | Associacao de Investigacao de Cuidados de Suporte em Oncologia | 2019-07-11 |
| A Study of the Drugs Talazoparib and Temozolomide in Prostate Cancer (NCT04019327) | Memorial Sloan Kettering Cancer Center | 2019-07-11 |
| 68Ga-RM2 Compared to 68Ga-PSMA-617 PET/CT for Intermediate Risk Prostate Cancer Imaging (NCT03606837) | University Hospital, Bordeaux | 2019-07-11 |
| Characterize Tumor Hypoxia by Magnetic Resonance Imaging (NCT03987568) | Wake Forest University Health Sciences | 2019-07-10 |
| Accumulation of Dietary Bioactives and Prostate Cancer (NCT04046653) | Quadram Institute Bioscience | 2019-07-03 |
| STHLM3 AS NorDCaP - a Followup Study of Men on Active Surveillance of Prostate Cancer (NCT04627948) | Karolinska Institutet | 2019-07-01 |
| Focal HDR Brachytherapy Boost to Stereotactic Radiotherapy (NCT04100174) | Centre hospitalier de l'Université de Montréal (CHUM) | 2019-07-01 |
| Defining Recurrent Disease With Axumin™ (NCT03996993) | Cancer Center of Irvine | 2019-07-01 |
| Faecal Incontinence in Prostate Cancer Survivors Treated Whith Radiotherapy (NCT04262609) | Consorci Sanitari de Terrassa | 2019-07-01 |
| High-intensity Focused Ultrasound Study (NCT03927924) | Chinese University of Hong Kong | 2019-06-25 |
| Spa Therapy for Upper or Lower Limb Lymphoedema (NCT03580109) | Association Francaise pour la Recherche Thermale | 2019-06-20 |
| Axumin PETMRI Imaging Following Focal Cryo-ablation (FCA) (NCT04009083) | NYU Langone Health | 2019-06-19 |
| A Study Evaluating the Safety, Pharmacokinetics and Efficacy of Ipatasertib Administered in Combination With Rucaparib in Participants With Advanced Breast, Ovarian Cancer, and Prostate Cancer. (NCT03840200) | Hoffmann-La Roche | 2019-06-12 |
| Assessing Radio-hybrid Prostate Specific Membrane Antigen (rhPSMA-7.3) (18F) in Healthy Volunteers and Subjects With Prostate Cancer (NCT03995888) | Blue Earth Diagnostics | 2019-06-11 |
| Trial of Acetylsalicylic Acid and Atorvastatin in Patients With Castrate-resistant Prostate Cancer (NCT03819101) | Gustave Roussy, Cancer Campus, Grand Paris | 2019-06-06 |
| Influence of EMT on CTCs and Disease Progression in Prostate Cancer (NCT04021394) | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 2019-06-05 |
| Vitamin D Supplementation in RNA-seq Profiles of Single-core Prostate Samples, Among Veterans (NCT04621500) | Medical University of South Carolina | 2019-06-04 |
| Single-Dose Image-Guided Radiotherapy With Urethral Sparing and DIL Boost for Intermediate-Risk Prostate Cancer (PROSINT II) (NCT04035642) | Fundacao Champalimaud | 2019-06-01 |
| Men Moving Forward: A Lifestyle Program for African-American Prostate Cancer Survivors (NCT03971591) | Medical College of Wisconsin | 2019-06-01 |
| ARRx in Combination With Enzalutamide in Metastatic Castration Resistant Prostate Cancer (NCT03300505) | University of Michigan Rogel Cancer Center | 2019-05-31 |
| Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors (NCT04354064) | Washington University School of Medicine | 2019-05-29 |
| Evaluation of Response to Abiraterone/Prednisone by Race/Ethnicity and Other Factors in Metastatic Hormone Naive Prostate Cancer (NCT03833921) | Martha Mims | 2019-05-23 |
| Prostate Cancer Detection Screening MRI Protocol (NCT04175730) | University of Illinois at Chicago | 2019-05-20 |
| Rucaparib in Nonmetastatic prOstAte With BRCAness (NCT03533946) | University of Utah | 2019-05-20 |
| Assessing Induction of Double Strand Breaks With Androgen Receptor Partial Agonist in Patients on Androgen Suppression (NCT03507608) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2019-05-10 |
| Ultralow Versus Standard Pneumoperitoneum Pressure (NCT03630393) | OhioHealth | 2019-05-09 |
| Biomarkers of Sulforaphane/Broccoli Sprout Extract in Prostate Cancer (NCT03665922) | University of Pittsburgh | 2019-05-01 |
| Salvage Hypofractionated Accelerated Versus Standard Radiotherapy for Biochemical Failure After Prostatectomy (NCT03920033) | Asan Medical Center | 2019-05-01 |
| Reduction of Prostate Biopsy Morbidity (NCT03913039) | Maimonides Medical Center | 2019-05-01 |
| WALNUTS for POWER: Polyphenols, Omega-3 Fatty Acids, Weight Loss, and EneRgy (NCT03824652) | Stephen Freedland | 2019-04-22 |
| PSMA-PET for Biopsy and Treatment Guidance in Primary Prostate Cancer (NCT03429244) | Indiana University | 2019-04-15 |
| Study With Bispecific Antibody Engaging T-cells, in Patients With Progressive Cancer Diseases With Positive PSCA Marker (NCT03927573) | AvenCell Europe GmbH | 2019-04-15 |
| A Study of Salvage Radiotherapy With or Without Enzalutamide in Recurrent Prostate Cancer Following Surgery (NCT03809000) | RTOG Foundation, Inc. | 2019-04-15 |
| MRx0518 in Patients With Solid Tumours Waiting Surgical Removal of the Tumour (NCT03934827) | Imperial College London | 2019-04-10 |
| Additional Treatments to the Local Tumour for Metastatic Prostate Cancer: Assessment of Novel Treatment Algorithms (NCT03763253) | Imperial College London | 2019-04-10 |
| 68-Ga PSMA 11 PET/MRI and 68-Ga RM2 PET/MRI for Evaluation of Prostate Cancer Response to HIFU Therapy (NCT03949517) | Andrei Iagaru | 2019-04-09 |
| A Study of SHR3680 in Combination With SHR3162 in the Treatment of mCRPC (NCT04102124) | Jiangsu HengRui Medicine Co., Ltd. | 2019-04-08 |